Takeda Pharmaceutical
TAK
$15.28
Share price
-1.23%
Change (1 day)
10.01%
Change (1 year)
Categories
EPS for Takeda Pharmaceutical (TAK)
EPS in 2023 (TTM): $0.70
According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is $0.70. In 2022 the company made an earnings per share (EPS) of $0.65 a decrease over its 2021 EPS that were of $1.26.
EPS history for Takeda Pharmaceutical from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.70 | 8.2% |
| 2022 | $0.65 | -48.38% |
| 2021 | $1.26 | 129.33% |
| 2020 | $0.55 | 1194.61% |
| 2019 | $0.04246 | -93.1% |
| 2018 | $0.62 | -43.22% |
| 2017 | $1.08 | 33.37% |
| 2016 | $0.81 | -236.78% |
| 2015 | -$0.59 | -294.41% |
| 2014 | $0.31 | -66.04% |
| 2013 | $0.90 | 9.95% |
| 2012 | $0.82 | -46.86% |
| 2011 | $1.54 | -18.07% |
| 2010 | $1.88 | -13.68% |
| 2009 | $2.18 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $4.97 | 606.16% | 🇺🇸 USA |
 Novartis NVS | $3.62 | 414.15% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.82 | 442.55% | 🇺🇸 USA |
 Amgen AMGN | $14.93 | 2,020.50% | 🇺🇸 USA |
 Sanofi SNY | $2.93 | 316.76% | 🇫🇷 France |
 Merck MRK | $1.23 | 74.70% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $8.34 | 1,084.09% | 🇬🇧 UK |
 Seagen
SGEN | -$3.89 | -652.49% | 🇺🇸 USA |
 Dr. Reddy's RDY | $3.47 | 392.38% | 🇮🇳 India |